Muscle Testing to Predict Heart Risk After ICD
Part of Brain & nervous system, Heart & circulation clinical trials.
This study looks at muscle health in people getting their first implantable defibrillator (ICD) to better predict risk of sudden cardiac death. It involves checking muscle mass and strength before and after the device is placed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are getting an implantable cardioverter-defibrillator (ICD) for the first time.
- You have had a full check for sarcopenia (loss of muscle mass and strength).
- You are willing to come back for regular follow-ups.
- You do not have serious heart valve disease or a history of valve surgery.
- Your ICD is placed inside the heart (not under the skin).
- You do not have conditions like cancer or serious liver/kidney disease that affect muscles.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether implanting a defibrillator (ICD) soon after a heart attack can lower the risk of sudden cardiac death in people with weaker heart pumping and symptoms of heart failure. It compares strategies around defibrillator implantation, aiming to improve safety and outcomes.
This trial tests whether a programmed heart rhythm test can better identify who needs an implanted defibrillator (ICD) soon after a heart attack. It may help prevent dangerous fast heart rhythms (tachyarrhythmias) by guiding who gets an ICD.
This trial tests whether using an MRI to guide the placement of a defibrillator (ICD) helps people with weak hearts. It might offer a more precise way to implant the device.
This trial tests whether combining modern heart failure medications with an implantable defibrillator (ICD) can reduce the risk of dangerous heart rhythms and improve survival in people with dilated cardiomyopathy. It focuses on those with a weak heart pump and specific scarring seen on MRI.
This study looks at how the heart's electrical signals can predict sudden cardiac arrest in people with a weakened heart muscle. It may help doctors identify who is at highest risk.
This study looks at whether implantable defibrillators can reduce dangerous heart rhythms in people with non-ischemic cardiomyopathy (heart weakness not caused by blocked heart arteries), a heart scar, and very low pumping strength despite best treatment. It compares different approaches to choosing which patients should receive these devices.
Hear when a new Sudden Cardiac Death trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.